Winslow Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-419
| Closed | -$203K | – | 73 |
|
|
2025
Q1 | $203K | Buy |
+419
| New | +$203K | ﹤0.01% | 63 |
|
|
2024
Q4 | – | Sell |
-516
| Closed | -$240K | – | 70 |
|
|
2024
Q3 | $240K | Sell |
516
-6
| -1% | -$2.79K | ﹤0.01% | 61 |
|
|
2024
Q2 | $245K | Sell |
522
-92
| -15% | -$43.1K | ﹤0.01% | 55 |
|
|
2024
Q1 | $257K | Sell |
614
-924,755
| -100% | -$387M | ﹤0.01% | 55 |
|
|
2023
Q4 | $377M | Sell |
925,369
-194,223
| -17% | -$79M | 1.56% | 21 |
|
|
2023
Q3 | $389M | Sell |
1,119,592
-19,349
| -2% | -$6.73M | 1.85% | 19 |
|
|
2023
Q2 | $401M | Buy |
1,138,941
+650,966
| +133% | +$229M | 1.8% | 17 |
|
|
2023
Q1 | $154M | Buy |
+487,975
| New | +$154M | 0.78% | 43 |
|
|
2016
Q1 | – | Sell |
-2,501,991
| Closed | -$315M | – | 156 |
|
|
2015
Q4 | $315M | Sell |
2,501,991
-419,795
| -14% | -$52.8M | 1.13% | 42 |
|
|
2015
Q3 | $304M | Sell |
2,921,786
-105,356
| -3% | -$11M | 1.11% | 42 |
|
|
2015
Q2 | $374M | Sell |
3,027,142
-648,273
| -18% | -$80M | 1.24% | 29 |
|
|
2015
Q1 | $434M | Buy |
3,675,415
+1,850,944
| +101% | +$218M | 1.34% | 32 |
|
|
2014
Q4 | $217M | Buy |
+1,824,471
| New | +$217M | 0.67% | 59 |
|